Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

37.65
+0.72001.95%
Volume:2.50M
Turnover:94.14M
Market Cap:43.86B
PE:62.75
High:37.85
Open:37.15
Low:37.12
Close:36.93
52wk High:37.85
52wk Low:17.82
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.53
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.66
PE(LYR):31.12

Loading ...

Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report